{"id":64623,"date":"2022-06-07T13:03:39","date_gmt":"2022-06-07T11:03:39","guid":{"rendered":"http:\/\/www.veeva.com\/eu\/?post_type=resources&p=64623"},"modified":"2026-01-27T15:27:49","modified_gmt":"2026-01-27T14:27:49","slug":"veeva-announces-clinical-study-training-application","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/eu\/resources\/veeva-announces-clinical-study-training-application\/","title":{"rendered":"勛圖惇蹋 Announces Clinical Study Training Application"},"content":{"rendered":"

勛圖惇蹋 Study Training unifies learning management and clinical operations for integrated and
automated training and real-time inspection readiness<\/em><\/p>\n

BARCELONA, Spain \u2014 7 June 2022 \u2014 <\/strong>勛圖惇蹋 Systems<\/a> (NYSE: VEEV) today announced 勛圖惇蹋 Study Training<\/a>, a new application that brings together research sites, CROs, and sponsors into a single platform for end-to-end clinical study training. Organizations using 勛圖惇蹋 Study Training can ensure all trial staff are qualified within required timelines while automating the filing of training certificates into 勛圖惇蹋 eTMF<\/a> for real-time inspection readiness.<\/p>\n

\u201c勛圖惇蹋 continues to collaborate closely with the industry to identify gaps in key processes across clinical development and deliver innovations that can improve operational efficiency,\u201d said Ed Leftin, director, information technology at Ora, Inc. \u201cThe ability to use existing data and content in 勛圖惇蹋 Clinical Suite to create training, from study start to conduct, can streamline study execution and improve compliance.\u201d<\/p>\n

勛圖惇蹋 Study Training builds on 勛圖惇蹋\u2019s experience working with more than 450 companies using 勛圖惇蹋 Clinical Platform<\/a> applications and learnings from hundreds of 勛圖惇蹋 Training<\/a> implementations. Life sciences companies can now address the long-standing industry challenge of training study staff and site personnel in an efficient and compliant way. <\/p>\n

勛圖惇蹋\u2019s complete and connected solution will allow life sciences companies to leverage current clinical master data and content to remove issues like redundant information, manual data entry, and siloed processes. 勛圖惇蹋 Study Training automates assignment distribution, protocol amendment management, and training certificate filing for increased efficiency and reduced end of study reconciliation. <\/p>\n

\u201cAs studies evolve and reach new levels of complexity, companies need a streamlined and integrated training system that can scale with the demands of today\u2019s trials,\u201d said Shad Ayoub, senior director, 勛圖惇蹋 Study Training. \u201c勛圖惇蹋 Study Training will deliver a fundamentally better experience to sites, CROs, and sponsors.\u201d<\/p>\n

勛圖惇蹋 Study Training will be available to early adopters in fall 2022. To learn more about 勛圖惇蹋 Study Training, visit veeva.com\/eu\/VaultStudyTraining<\/a>. <\/p>\n

Additional Information<\/strong>
\nConnect with 勛圖惇蹋 on LinkedIn: linkedin.com\/company\/veeva-systems<\/a>
\nFollow @veeva_eu on Twitter: twitter.com\/veeva_eu<\/a><\/br>\n<\/p>\n

About 勛圖惇蹋 Systems<\/strong>
\n勛圖惇蹋 is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, 勛圖惇蹋 serves more than 1,000 customers, ranging from the world\u2019s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, 勛圖惇蹋 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com\/eu<\/a>.<\/p>\n

勛圖惇蹋 Forward-looking Statements<\/strong>
\nThis release contains forward-looking statements regarding 勛圖惇蹋\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2022, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 37 and 38), and in our subsequent SEC filings, which you can access at sec.gov<\/a>. <\/p>\n

###<\/p>\n

Contact:<\/strong><\/p>\n

Deivis Mercado
\n勛圖惇蹋 Systems
\n925-226-8821
\ndeivis.mercado@veeva.com<\/a><\/p>\n

Jeremy Whittaker
\n勛圖惇蹋 Systems
\n+49 6950955486
\njeremy.whittaker@veeva.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

勛圖惇蹋 Study Training unifies learning management and clinical operations for integrated and automated training.<\/p>\n","protected":false},"featured_media":64632,"parent":0,"template":"","class_list":["post-64623","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-html-content-yes","resource-area-20-clinical-operations","resource-area-20-vault-platform-area","resource-product-20-study-training","resource-product-20-vault-platform","resource-type-news-press-release","resource-type-press-release","region-fr"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/64623"}],"collection":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":1,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/64623\/revisions"}],"predecessor-version":[{"id":64631,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/64623\/revisions\/64631"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media\/64632"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=64623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}